Over the past 200 years JM has established itself as a world leader within the Pharma industry

Nasal-bound nanoparticles could offer a novel way to bypass the blood-brain barrier

As Article 50's clock continues to tick, will the UK reconsider EEA/EFTA membership?

Boosting the body's built-in cannabinoid signaling receptors

The International Cannabinoid Research Society was formed in the early 1990s – and continues to grow

How will pharmacovigliance in the UK and Europe be affected by Brexit?

Patheon's Steve Lam shares his lessons learned over three decades in bioprocessing.

What do trends in small molecule drugs mean for contract manufacturers?

Pfizer researchers share the story behind the first JAK inhibitor for rheumatoid arthritis

Advanced tools to unlock the potential for better products